Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Cell Therapeutics Inc.
Penalty: $10,500,000
Year: 2007
Date: April 17, 2007
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: kickbacks and bribery
Violation Description: Cell Therapeutics Inc. has agreed to pay the United States $10.5 million to resolve allegations of the company's improper marketing of the anti-cancer prescription drug Trisenox. According to the government's complaint, CTI promoted the drug for various uses that were unapproved by the Food & Drug Administration.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.